IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Bafna Pharmaceuticals Limited is an Pharmaceutical based company, located in Chennai, Bafna Pharmaceuticals Limited IPO size was 25.60 Cr. and was issued at 40.00 per share. The share of Bafna Pharmaceuticals Limited were listed at 38.50 per share and are currently trading at per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Bafna Pharmaceuticals operates in Pharmaceutical and Pharmaceutical. The Issue is listed on BSE,NSE in Jun, 2008. Bafna Pharmaceuticals IPO size was 25.60 Cr. with Issue price of 40.00 .
Merchant Banker(s) of Bafna Pharmaceuticals IPO: Keynote Financial Services Limited , Ashika Capital Limited
Bafna Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bafna Pharmaceuticals IPO listed at a listing price of 38.50 against the offer price of 40.00.
The current market price of Bafna Pharmaceuticals is .
Why Us?
